Primitive Neuroectodermal Tumor Presenting with Elevating Carcinoembryonic Antigen  by Cheng, Hsiao-Hsiang & Liaw, Chuang-Chi
 Case Report  
Primitive Neuroectodermal Tumor Presenting with Elevating 
Carcinoembryonic Antigen 
Hsiao-Hsiang Cheng, Chuang-Chi Liaw* 
Division of Hematology and Oncology, Department of Internal Medicine, Chang Gung Medical Foundation, Lin-Kuo 
Branch, Taiwan 
Abstract. 
Primitive neuroectodermal tumor (PNET) is a rare disease and mostly diagnosed in chil-
dren and young adults. This tumor is presumed to be of neuroectodermal origin, probably de-
veloping from migrating embryonic cells of the neural crest. Carcinoembryonic antigen is a 
glycoprotein and frequently elevated in patients with a variety of epithelial malignancies. We 
report hereby a 59-year old male patient with pelvic PNET, and the initial presentation was 
merelyelevating serum CEA of unknown origin. This case might help to support the theory that 
PNET may have a potential for epithelial or neuroendocrine differentiation. 
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病例報告  
原始神經外胚層腫瘤患者伴隨血清腫瘤胎源抗原升高 
鄭小湘 廖宗琦* 
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中文摘要 
  原始神經外胚層腫瘤(PNET)是一種罕見的疾病，它主要發生於兒童和年輕成人。這
個腫瘤的起源是假設來自於神經外胚層，並猜測可能來自胚胎的神經脊細胞。腫瘤胎源
抗原(CEA)是一種糖蛋白；在某些上皮腫瘤的病患，它的數值常常會升高。我們報告一名
59 歲男性患者，診斷有骨盆腔的 PNET，而他開始最初的臨床表現是未明原因的血清 CEA
升高。這個病例或許可支持 PNET 的細胞有上皮或神經內分泌分化的能力。 
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INTRODUCTION 
In 1918, Stout described a tumor of the ulnar nerve 
with the gross features of a sarcoma, but composed of 
small round cells focally arranged as rosettes; and it 
was designated as neuroepithelioma first [1]. The 
concept of this entity evolved to include a group of 
small round-cell malignancies, ubiquitous in location 
and of presumed neuroectodermal origin, probably 
developing from migrating embryonic cells of the 
neural crest [2] and was called primitive neuroecto-
dermal tumor (PNET) [3]. This type of tumor is usu-
ally diagnosed in children and young adults [4]. Re-
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 cently, PNET and Ewing's sarcoma have been classi-
fied into the same tumor family on the basis of molec-
ular genetic analysis because of their similar histolog-
ic and immunohistochemical characteristics, also shar-
ing nonrandom chromosomal translocations [5,6]. 
Carcinoembryonic antigen (CEA) is an approxi-
mately 180 kDa glycoprotein, originally identified by 
in 1965 by Gold and Freedman [7,8]. Serum levels of 
CEA are frequently elevated in patients with a variety 
of epithelial malignancies [9-11]. 
There has been only one report of peripheral 
PNET/ Ewing's sarcoma/with elevated serum levels of 
CEA in the literature, and the case was a 7-year-old 
patient [12] . To the best of our knowledge, this is the 
first case of primary Ewing's sarcoma/peripheral 
PNET with elevated serum levels of CEA in an adult 
patient. 
 
CASE REPORT 
A 59-year-old man was referred to the out-patient 
department of medical oncology because of incidental 
finding of elevated CEA in a health examination. His 
initial CEA level was 44.13 ng/mL (normal value: < 5 
ng/ml for non-smokers and < 7 ng/mL for smokers). 
No headache, chest pain, abdominal pain, bone pain, 
cough, dyspnea, anorexia, general malaise, bowel 
habit change, body weight loss, or other symptoms 
were mentioned. The pateint had hypertension and 
diabetes mellitus with regular medical control. He de-
nied smoking and alcohol use. He was 166 cm in 
height and 88 kg in weight and was fair looking. 
There was no abnormal finding in the physical exam- 
ination. On account of abnormal elevating of CEA 
without obvious symptoms or signs, we rechecked his 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Computed tomography scan of pelvis show-
ing a 3 x 3 cm mass in right rectoischial 
fossa 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Formalin-fixed excised round tumor showing 
lobulated, gray-white, and elastic contents 
 
 
 
 
 
 
 
 
Figure 3. Haematoxylin and eosin section showing 
malignant tumor composed of moderately 
uniform round and oval cells, and arranged 
in sheets and trabecules with cystic space 
and rossetts. The overall pattern favored a 
PNET. (Original magnification of 40x10) 
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Figure 4. Immunohistochemical staining showing diffuse positivity of tumor cells for CD99 (A) and CEA (B); 
focal positivity for vimentin (C) and NSE (D); and negativity for AE1/AE3 (E), EMA (F), and BCL-2 
(G). (Original magnification of 40x10) 
 
 
serum CEA, which was elevated to 56.9 ng/mL in one 
month. The hemogram and biochemistry were also in 
the normal range. The chest X-ray, panendoscopy, 
colonscopy, and liver echo all showed negative find-
ings. Then, chest, abdomen and pelvic computed to-
mography scans (CT scan) were arranged. There was 
no specific finding in the chest or abdomen, but a 
mass about 3x2 cm in dimension with a suspicious 
necrotic part was noted in the right rectoischial fossa 
(Figure 1).  
After discussion with the patient, an en bloc exci-
sion of the tumor was performed. A lobulated tumor, 
located at the apex of the ischiorectal space near the 
right pelvic sidewall was found. The size was 5x6x4 
cm, and the tumor had a heterogenous content (cystic 
and solid component) with no invasion to the sur-
rounding structures (Figure 2).  
Hemotoxyline and eosin staining (Figure 3) 
showed a malignant tumor composed of moderately 
uniform round and oval cells, arranged in sheets and 
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Figure 5. Computed tomography scan showing lung 
metastasis 
 
 
trabecules with cystic space and rossetts. Tumor 
nuclei were large with mitotic figures 7-10/10HPF, 
and necrosis was seen. Immunohiscochemical study 
showed that the tumor was diffusely positive with 
CD99 (MIC2) (Figure 4A), focally with vimentin and 
NSE (Neuron Specific Enolase) (Figure 4C,D). It was 
negative for AE1/AE3, EMA (Epithelial Membranous 
Antigen), or BCL-2 (B-cell lymphoma 2) (Figure 
4E-G). The overall pattern favored a PNET. As elevat 
ing serum CEA was noted, the tumor was also stained 
for CEA, which showed unusually diffuse positivity 
(Figure 4B).  
After the operation, the patient received adjuvant 
concurrent chemoradiotherapy. His serum CEA, orig-
inally 218.49 ng/mL before operation, decreased to 
73.4 ng/mL 2 weeks after the operation, and then 
dropped to 10.7 ng/ml 3 months after the operation 
when he finished his adjuvant therapy. But his serum 
CEA never returned to normal, and became gradually 
elevated during follow up. The repeat CT scan showed 
negative finding for tumor recurrence. Fourteen months 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Computed tomography scan showing progressive more extensive lung metastasis (A), local recurrence 
(B), and left rib metastasis (C) 
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 after the operation, the patient’s serum CEA elevated 
to 393.48 ng/mL, and a chest CT scan showed multi-
ple pulmonary metastasis (Figure 5). He hesitated for 
palliative chemotherapy. Five months later, the serum 
CEA level reached 1250 ng/mL and the CT scan 
demonstrated more extensive pulmonary metastasis, 
local recurrence, and left rib metastasis (Figure 6). 
Therefore, the patient started to receive palliative 
chemotherapy with epirubicin and ifosphamide. Un-
fortunately, he died of sepsis. The overall survival was 
approximately 24 months. 
 
DISCUSSION 
PNET is a rare and aggressive disease. There were 
only 17 diagnosed cases of PNET in Taiwan in 2008 
[13]. It is defined as embryonal tumors composed of 
undifferentiated or poorly differentiated neuroepithe-
lial cells which have the capacity for or display of di-
vergent differentiation along neuronal astrocytic, ep-
endymal, muscular or melanotic lines [14]. Morpho-
logically, the appearance of PNET tumors is similar to 
that of other small round blue cell tumors involving 
bone and soft tissue, including lymphoma, small cell 
osteosarcoma, mesenchymal chondrosarcoma, medul-
loblastoma, dedifferentiated synovial sarcoma, desmo-
plastic small round cell tumors, and rhabdomyosar-
coma. As a group, these tumors often pose difficult 
diagnostic problems when examined by light micros-
copy alone. Nowadays, demonstration of MIC2 gly-
coprotein expression by immunocytochemical staining 
(CD99) aids in diagnosis of PNET [15,16]. In our case, 
the H.E staining showed typical findings of PNET, 
and the immunohistochemistry study also confirmed 
the diagnosis (positive for CD99). As the initial 
presentation of the case was elevating serum CEA, we 
also stained he tumor with CEA to see if the tumor 
was CEA-producting. The result was positive and the 
patient’s serum CEA fluctuated as his disease course 
changed. The fluctuation of the serum CEA levels 
confirmed the patient’s PNET was CEA-producting. 
Carcinoembryonic antigen (CEA) is a 180 kDa 
GPI-linked cell-surface glycoprotein normally ex-
pressed in the fetal gut and on the luminal surface of 
the adult colon [8,17]. During colorectal carcinoma 
oncogenesis, CEA loses its polarity and becomes 
overexpressed throughout the tumor tissue. High lev-
els of CEA expression have also been observed in ep-
ithelial tumors in the lung [18,19], breast [20], thyroid 
[21-23], and ovaries [24]. 
PNET is in the same family as Ewing’s sarcoma. 
Ewing’s sarcoma family of tumors (ESFT) have been 
found to have potential for epithelial differentiation. 
The immunohistochemial (IHC) study of Machado et 
al confirmed the epithelial marker expression of EMA 
and CEA in ESFT. Thus, epithelial marker expression 
does not necessarily rule out the diagnosis of ESFT. In 
the study of Machadol et al, 57 (20.8%) out of 415 
specimens of ESFT had stained positive for CEA. 
However, no correlation was shown between epithelial 
marker expression and histological subtypes of ESFT 
[25]. Further or more advanced molecular genetic 
techniques are necessary to confirm the diagnosis of 
sarcoma. Our patient did not have the study of reverse 
transcription polymerase chain reaction (RT-PCR) to 
demonstrate the EWS-FLI1 fusion gene because the 
technique was unavailable in our hospital at that time. 
Our case also suggested that PNET might have 
potential for epithelial or neuroendocrine differentia-
tion. However, more data are necessary to support this 
statement. 
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